Intra-arterial delivery of cell therapies for stroke

Stem Cells and Development

Volumn 21, Issue 7, 2012, Pages 1007-1015

  Misra, Vivek ^a   Lal, Aditya ^a   El Khoury, Ramy ^a   Chen, Peng R ^a   Savitz, Sean I ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; DOBUTAMINE; FIBRINOGEN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HEPARIN; NEUROTROPHIC FACTOR; NICORANDIL; SUPERPARAMAGNETIC IRON OXIDE; TISSUE PLASMINOGEN ACTIVATOR; VERAPAMIL;

ADJUVANT THERAPY; ANKLE BRACHIAL INDEX; ARTERY DISSECTION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BALLOON CATHETER; BIOCOMPATIBILITY; BONE MARROW CELL; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PERFUSION; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CATHETER; CELL LABELING; CELL THERAPY; CENTRAL RETINA ARTERY OCCLUSION; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICES; FEMORAL ARTERY; HEART ARRHYTHMIA; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INJECTION SITE; MESENCHYMAL STEM CELL; MIDDLE CEREBRAL ARTERY; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT MONITORING; PATIENT SAFETY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; SHY DRAGER SYNDROME; STROKE; TREATMENT OUTCOME; ULCER HEALING; VASOSPASM;

ANIMALS; CELL TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; HUMANS; INJECTIONS, INTRA-ARTERIAL; NERVOUS SYSTEM DISEASES; STROKE;

EID: 84860175227     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0612     Document Type: Review

References (61)

1. Walker PA, MT Harting, SK Shah, MC Day, R El Khoury, SI Savitz, J Baumgartner and CS Cox. (2010). Progenitor cell therapy for the treatment of central nervous system injury: a review of the state of current clinical trials. Stem Cells Int 2010:369578.
2. Sanberg PR, DJ Eve, AE Willing, S Garbuzova-Davis, J Tan, CD Sanberg, JG Allickson, LE Cruz and CV Borlongan. (2011). The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant 20:85-94.
3. Savitz SI, V Misra, M Kasam, H Juneja, CS Cox Jr, S Alderman, I Aisiku, S Kar, A Gee and JC Grotta. (2011). Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 70:59-69.
4. Battistella V, GR de Freitas, LM da Fonseca, D Mercante, B Gutfilen, RC Goldenberg, JV Dias, TH Kasai-Brunswick, E Wajnberg, et al. (2011). Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 6:45-52.
5. Adams HP Jr, G del Zoppo, MJ Alberts, DL Bhatt, L Brass, A Furlan, RL Grubb, RT Higashida, EC Jauch, et al. (2007). Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115:e478-e534.
6. Fischer UM, MT Harting, F Jimenez, WO Monzon-Posadas, H Xue, SI Savitz, GA Laine and CS Cox Jr. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:683-692.
7. Kamiya N, M Ueda, H Igarashi, Y Nishiyama, S Suda, T Inaba and Y Katayama. (2008). Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci 83:433-437.
8. Pendharkar AV, JY Chua, RH Andres, N Wang, X Gaeta, H Wang, A De, R Choi, S Chen, et al. (2010). Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 41:2064-2070.
9. Walczak P, J Zhang, AA Gilad, DA Kedziorek, J Ruiz-Cabello, RG Young, MF Pittenger, PC van Zijl, J Huang and JW Bulte. (2008). Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39:1569-1574.
10. Li Y, M Chopp, J Chen, L Wang, SC Gautam, YX Xu and Z Zhang. (2000). Intrastriatal transplantation of bone marrow nonhemapoitic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 20:1311-1319.
11. Olanow CW, CG Goetz, JH Kordower, AJ Stoessl, V Sossi, MF Brin, KM Shannon, GM Nauert, DP Perl, J Godbold and TB Freeman. (2003). A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54:403-414.
12. Li L, Q Jiang, G Ding, L Zhang, ZG Zhang, Q Li, S Panda, M Lu, JR Ewing and M Chopp. (2010). Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 30:653-662.
13. Kondziolka D, GK Steinberg, L Wechsler, CC Meltzer, E Elder, J Gebel, S Decesare, T Jovin, R Zafonte, et al. (2005). Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103:38-45.
14. Savitz SI, J Dinsmore, J Wu, GV Henderson, P Stieg and LR Caplan. (2005). Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 20:101-107.
15. Assmus B, J Honold, V Schächinger, MB Britten, U Fischer- Rasokat, R Lehmann, C Teupe, K Pistorius, H Martin, et al. (2006). Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355:1222-1232.
16. Lunde K, S Solheim, S Aakhus, H Arnesen, M Abdelnoor, T Egeland, K Endresen, A Ilebekk, A Mangschau, et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 355:1199-1209.
17. Tendera M, W Wojakowski, W Ruzy11o, L Chojnowska, C Kepka, W Tracz, P Musia1ek, W Piwowarska, J Nessler, et al.; REGENT Investigators. (2009). Intracoronary infusion of bone marrow-derived selected CD34 + CXCR4 + cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30:1313-1321.
18. Kang HJ, HS Kim, SY Zhang, KW Park, HJ Cho, BK Koo, YJ Kim, D Soo Lee, DW Sohn, et al. (2004). Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 363:751-756.
19. Lipinski MJ, GG Biondi-Zoccai, A Abbate, R Khianey, I Sheiban, J Bartunek, M Vanderheyden, HS Kim, HJ Kang, BE Strauer and GW Vetrovec. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50:1761-1767.
20. Traverse JH, DH McKenna, K Harvey, BC Jorgenso, RE Olson, N Bostrom, D Kadidlo, JR Lesser, V Jagadeesan, R Garberich and TD Henry. (2010). Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. Am Heart J 160:428-434.
21. Wollert KC, GP Meyer, J Lotz, S Ringes-Lichtenberg, P Lippolt, C Breidenbach, S Fichtner, T Korte, et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148.
22. Schaefer A, GP Meyer, M Fuchs, G Klein, M Kaplan, KC Wollert and H Drexler. (2006). Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial. Eur Heart J 27:929-935.
23. Meyer GP, KC Wollert, J Lotz, J Steffens, P Lippolt, S Fichtner, H Hecker, A Schaefer, L Arseniev, et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113:1287-1294.
24. Assmus B, V Schächinger, C Teupe, M Britten, R Lehmann, N Döbert, F Grünwald, A Aicher, C Urbich, et al. (2002). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009-3017.
25. Schächinger V, B Assmus,MB Britten, JHonold, R Lehmann, C Teupe, ND Abolmaali, TJ Vogl, WK Hofmann, et al. (2004). Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44:1690-1699.
26. Schächinger V, S Erbs, A Elsässer, W Haberbosch, R Hambrecht, H Hölschermann, J Yu, R Corti, DG Mathey, et al.; REPAIR-AMI Investigators. (2006). Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210-1221.
27. Schächinger V, S Erbs, A Elsässer, W Haberbosch, R Hambrecht, H Hölschermann, J Yu, R Corti, DG Mathey, et al.; REPAIR-AMI Investigators. (2006). Improved clinical outcome after intracoronary administration of bone-marrowderived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27:2775-2783.
28. Assmus B, A Rolf, S Erbs, A Elsässer, W Haberbosch, R Hambrecht, H Tillmanns, J Yu, R Corti, et al.; REPAIR-AMI Investigators. (2010). Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circ Heart Fail 3:89-96.
29. Janssens S, C Dubois, J Bogaert, K Theunissen, C Deroose, W Desmet, M Kalantzi, L Herbots, P Sinnaeve, et al. (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 367:113-121.
30. Chen SL, WW Fang, F Ye, YH Liu, J Qian, SJ Shan, JJ Zhang, RZ Chunhua, LM Liao, S Lin and JP Sun. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95.
31. Bartunek J, M Vanderheyden, B Vandekerckhove, S Mansour, B De Bruyne, P De Bondt, I Van Haute, N Lootens, G Heyndrickx and W Wijns. (2005). Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112:I178-I183.
32. Yousef M, CM Schannwell, M Köstering, T Zeus, M Brehm and BE Strauer. (2009). The BALANCE study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. J Am Coll Cardiol 53:2262-2269.
33. Ruiz-Salmeron R, A de la Cuesta-Diaz, M Constantino- Bermejo, I Pérez-Camacho, F Marcos-Sánchez, A Hmadcha and B Soria. (2011). Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischaemia. Cell Transplant. 20:1629-1639.
34. Bartsch T, M Brehm, T Zeus and BE Strauer. (2006). Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nurs 21:430-432.
35. Walter DH, H Krankenberg, JO Balzer, C Kalka, I Baumgartner, M Schlüter, T Tonn, F Seeger, S Dimmeler, E Lindhoff-Last and AM Zeiher; PROVASA Investigators. (2011). Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 4:26-37.
36. Van Tongeren RB, JF Hamming, WE Fibbe, V Van Weel, SJ Frerichs, AM Stiggelbout, JH Van Bockel and JH Lindeman. (2008). Intramuscular or combined intramuscular/intraarterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino) 49:51-58.
37. Lenk K, V Adams, P Lurz, S Erbs, A Linke, S Gielen, A Schmidt, D Scheinert, G Biamino, et al. (2005). Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J 26:1903-1909.
38. Mendonça ML, GR Freitas, SA Silva, A Manfrim, CH Falcão, C Gonzá les, C André, HF Dohmann, R Borojevic and RM Otero. (2006). Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke. Arq Bras Cardiol 86:52-55.
39. Correa PL, CT Mesquita, RM Felix, JC Azevedo, GB Barbirato, CH Falcão, C Gonzáles, ML Mendonça, A Manfrim, et al. (2007). Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clin Nucl Med 32:839-841.
40. Clinical trial.gov identifier NCT01273337. http://clinicaltrials.gov/ct2/ show/NCT01273337?term=NCT01273337&rank=1 (Accessed August 20, 2011).
41. Yavagal DR, B Lin, P Garza, T Pham, SM Amatangelo, AR Raval, M Perez-Pinzon, I McNiece, T Rundek and JM Hare. Efficacy of Maximum Tolerated Dose of Intra-Carotid Mesenchymal StemCells in Reversible Subacute Middle Cerebral Artery Occlusion. Abstract presented at American Academy of Neurology (AAN) 2011 Annual meeting, Honolulu, HI.
42. Yavagal DR, T Pham, B Lin, S Dharmadhikari, P Garza, I McNiece, M Perez-Pinzon and JM Hare. Acute Intra-Carotid Delivery of Mesenchymal Stem Cells in Middle Cerebral Artery Occlusion. Abstract presented at American Academy of Neurology (AAN) 2011 Annual meeting, Honolulu, HI.
43. Clinical trial.gov identifier NCT00535197. http://clinicaltrials.gov/ct2/ show/NCT00535197?term=NCT00535197&rank=1 (Accessed August 20, 2011).
44. Clinical trial.gov identifier NCT00473057. http://clinicaltrials.gov/ct2/ show/NCT00473057?term=NCT00473057&rank=1 (Accessed August 20, 2011).
45. Clinical trial.gov identifier NCT00761982. http://clinicaltrials.gov/ct2/ show/NCT00761982?term=NCT00761982&rank=1 (Accessed August 20, 2011).
46. Lee PH, JW Kim, OY Bang, YH Ahn, IS Joo and K Huh. (2008). Autologous Mesenchymal Stem Cell Therapy Delays the Progression of Neurological Deficits in Patients With Multiple System Atrophy. Clin Pharmacol Ther 83:723-730.
47. Brazzini A, R Cantella, A De la Cruz, J Yupanqui, C León, T Jorquiera, M Brazzini, M Ortega and LN Saenz. (2010). Intraarterial Autologous Implantation of Adult Stem Cells for Patients with Parkinson Disease. J Vasc Interv Radiol 21:443-451.
48. Strauer BE, M Brehm, T Zeus, M Köstering, A Hernandez, RV Sorg, G Kögler and P Wernet. (2002). Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918.
49. Syková E, P Jendelová and V Herynek. (2011). Magnetic resonance imaging of stem cell migration. Methods Mol Biol 750:79-90.
50. Bharadvaj BK, RF Mabon and DP Giddens. (1982). Steady flow in a model of the human carotid bifurcation. Part I- flow visualization. J Biomech 15:349-362.
51. Tanriover N, M Kawashima, AL Rhoton Jr, AJ Ulm and RA Mericle. (2003). Microsurgical anatomy of the early branches of the middle cerebral artery: morphometric analysis and classification with angiographic correlation. J Neurosurg 98:1277-1290.
52. Jun P, NU Ko, JD English, CF Dowd, VV Halbach, RT Higashida, MT Lawton and SW Hetts. (2010). Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 31:1911-1916.
53. Schumacher M, D Schmidt and AK Wakhloo. (1993). Intraarterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 35:600-605.
54. Richard G, RC Lerche, V Knospe and H Zeumer. (1999). Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 106:768-773.
55. RibóM, C Molina, B Alvarez, L Dinia, J Alvarez-Sabin and M Matas. (2009). Buying time for recanalization in acute stroke: arterial blood infusion beyond the occluding clot as a neuroprotective strategy. J Neuroimaging 19:188-190.
56. Ribo M, M Rubiera, J Pagola, D Rodriguez-Luna, P Meler, A Flores, J Alvarez-Sabin and CA Molina. (2010). Bringing forward reperfusion with oxygenated blood perfusion beyond arterial occlusion during endovascular procedures in patients with acute ischemic stroke. AJNR Am J Neuroradiol 31:1899-1902.
57. El Khoury R, V Misra, S Sharma, CS Cox, P Walker, JC Grotta, A Gee, S Suzuki and SI Savitz. (2010). The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells. AJNR Am J Neuroradiol 31:1488-1492.
58. Ries T, S Siemonsen, U Grzyska, H Zeumer and Fiehler J. (2009). Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of the literature. Stroke 40:1750-1757.
59. Chua JY, AV Pendharkar, N Wang, R Choi, RH Andres, X Gaeta, J Zhang, ME Moseley and R Guzman. (2011). Intraarterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab 31:1263-1271.
60. Lim SY, YS Kim, Y Ahn, MH Jeong, MH Hong, SY Joo, KI Nam, JG Cho, PM Kang and JC Park. (2006). The effects of mesenchymal stem cells transduced with akt in a porcine myocardial infarction model. Cardiovasc Res 70:530-542.
61. Kim BO, H Tian, K Prasongsukarn, J Wu, D Angoulvant, S Wnendt, A Muhs, D Spitkovsky and RK Li. (2005). Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112 (9 Supp. l):I96-I104.